CD274 and breast cancer: To enhance the efficacy of crotonate and overcome resistance to anti-PD-L1 therapy in mammary tumors, we treated immunocompetent mice bearing Py8119 cell–derived mammary tumors with crotonate alone, anti-PD-L1 antibody alone, or a combination of both (Fig. 7M).